IJPR  articles are Indexed in SCOPUSClick Here     Impact Factor for Five Years is 0.13 (2013 - 2018).    

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

ISSN
0975-2366
5 - Years Impact Factor

Year 2012 - 2016

Impact Factor: 1.55

Total Publications: 317

Total Citation: 491

Year 2011 - 2015

Impact Factor: 1.46

Total Publications: 326

Total Citation: 477

Year 2010 - 2014

Impact Factor: 1.3

Total Publications: 313

Total Citation: 407

Year 2009 - 2013

Impact Factor: 0.973

Total Publications: 293

Total Citation: 285

Current Issue
22nd NATIONAL CONVENTION

22nd National Convention of Society of Pharmacognosy & International Conference. For more details visit


For More Detail Visit ncsp.ganpatuniversity.ac.in
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPRT ISSUE

January - March 6 [1] 2014

Click to download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
QUALITY BY DESIGN (QBD) ASSISTED STATISTICAL MODELLING AND EX VIVO PERMEATION STUDY OF OLANZAPINE LOADED MICROEMULSION

Author: MANISH UPADHYAY, VIJAY GHORI, M.M.SONIWALA
Abstract: The present study was aimed towards development and characterization of Olanzapine (OZ) loaded microemulsion (ME) for brain delivery through nasal route. More emphasize was given in the present work is application of QbD tools and DoE approach. Different QTPP and CQAs were identified initially and REM was prepared. Further D optimal design was employed with concentration of Oil (A;X1), concentration of Smix (B;X2) and concentration of water (C;X3) as significant independent variables (IVs). Globule size (Y1), %Transmittance (Y2) and Viscosity (Y3) were kept as important CQAs. MLR models revealed that selected IVs have great impact on Y1 and Y3, specially main and interactive effect. The results were supported by contour plots (2D and3D) and predicated Vs actual plot.% PE values for check point batches were found less than 5% indicating accuracy of evolved MLR models. Further, control space was mapped from design space of overlay plot and out of control space, one batch was optimized and revised REM was prepared. Revised REM showed low risk potential of various IVs on selected CQAs.Optimized batch was tested for ex vivo permeation using sheep nasal mucosa in SNF. The study revealed that superior permeation than OZ suspension which is attributed to the incorporation of OZ into ME carrier. So, in a nutshell, it can be concluded that application of QbD tools and DoE concepts in OZ loaded ME yielded risk free control space which will be useful for error free scale up plan execution.
Keyword: Olanzapine, QbD, Risk assessment, DoE, Control space
DOI: https://doi.org/10.31838/ijpr/2019.11.03.016
Download: Request For Article
 












ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
Pharmacovigilance: Current Scenario and Emerging Trends

National Conference sponsored by GUJCOST on 03.08.2019 at SNLPCP, Umrakh

Download Brochure
News & Events
0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free
0.07
2017CiteScore
 
11th percentile
Powered by  Scopus
Impact Factor for five years is 1.55 (2012 - 2016)

Year 2011 - 2015 Impact Factor - 1.46 Total Publications - 326 Total Citations - 477